Cases & Deals

NGM develops global patent portfolio for beta-klotho antibodies

Clients NGM Biopharmaceuticals, Inc.

Jones Day represents NGM Biopharmaceuticals, Inc. in the development of a global patent portfolio for antibodies to beta-klotho for the treatment of diabetes and other metabolic disorders.